PPT-Antisense Oligonucleotide (ASO) Treatment in Epilepsy
Author : hazel | Published Date : 2022-06-15
Miriam Meisler Ph D Department of Human Genetics University of Michigan Ann Arbor MI Epilepsy Genetics Update 2020 Cleveland Clinic Neurological Institute
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Antisense Oligonucleotide (ASO) Treatmen..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Antisense Oligonucleotide (ASO) Treatment in Epilepsy: Transcript
Miriam Meisler Ph D Department of Human Genetics University of Michigan Ann Arbor MI Epilepsy Genetics Update 2020 Cleveland Clinic Neurological Institute . Gaetha Mills, RN, CNRN. 4. bed monitoring unit (with 4 additional beds being constructed). 5 epilepsy fellowship trained . Epileptologists. An. . epilepsy fellowship trained . Neurosurgeon. 4 epilepsy trained neuropsychologists. Natalie Hendon MD. Virginia Mason Medical Center. February 21, 2015. Learning Objectives. Medical use of cannabis. 2700 BCE – Chinese physicians. Treatment of menstrual disorders, gout, rheumatism, malaria, constipation, and absent-mindedness. at Queen’s Park. October 27, 2015. 15 . epilepsy agencies across Ontario represent nearly 90,000 people living with epilepsy. . Epilepsy agencies provide direct support to a sub-set of individuals and families living with epilepsy.. CLAE 2016. Dr. Mark Sadler. Dalhousie University. Halifax, NS. Disclosures. I have received honoraria from Eisai and UCB Canada. I have no disclosures relevant to this presentation. Previous Speakers. New, alternative, and experimental. Olgica Laban-Grant, MD. Northeast Regional Epilepsy Group. Seizures are defined as abnormal discharge of electrical activity of brain resulting in transient impairment of motor, sensory or mental function.. What is epilepsy?. Why should we learn about epilepsy?. Medical aspects of epilepsy. Common myths and misconceptions about epilepsy. What can you do to mitigate the problem?. Summary . 2. Dr R P Joshi. Redab. . Al-. Ghawanmeh. Objectives. Definitions. Epidemiology. Classification. Etiology. Epileptic . syndroms. Treatment. Prognosis. Disorders that mimic seizures. Definitions. Seizure. Epilepsy. Status . By. . NARENDAR.D. M.PHARM.. II - SEMESTER . . . Department of Pharmaceutics. University College of Pharmaceutical Sciences,. KAKATIYA UNIVERSITY. Why Target RNA for Therapeutics?. RNA therapeutics as a platform is a revolutionary approach to discover new and important therapeutic agents for treating human diseases. RNA as a class of molecules plays a major role in the regulation of biological processes and in human diseases. F.A.C.E.S. Conference. May 5, 2013. Diagnosis and Treatment of Mood Disorders in Epilepsy. What is Mood?. Emotional State or Frame of Mind. Not an Emotion, less specific. A Weather. Not Temperament or Personality (which are more like a climate). Patricia Dugan, . MD. Assistant Professor of Neurology. NYU . Langone. Medical Center. May . 5. , . 2012. Epilepsy is a common disorder. Estimated 2.2 million people with epilepsy in US (IOM report 2012). CNS STIMULANTS. Mr. ALETI VAMSI. Assistant Professor. Department of Pharmaceutical Chemistry. M.A.M College of Pharmacy, Narasaraopet. 1. Epilepsy is a collective designation for a group of chronic CNS disorders having in common the occurrence of brief and self limited ,sudden, and transitory seizures of abnormal motor , sensory , autonomic or psychic origin resulting into a repeated neuronal discharge . GET: Gene, . Epilepsy, Treatment. Designed & Developed by:. Ali A. Asadi-Pooya, M.D. ., Professor . of . Epileptology. Shiraz . University of Medical . Sciences, Shiraz. , . Iran. Thomas . Jefferson . October 27, 2015. 15 . epilepsy agencies across Ontario represent nearly 90,000 people living with epilepsy. . Epilepsy agencies provide direct support to a sub-set of individuals and families living with epilepsy..
Download Document
Here is the link to download the presentation.
"Antisense Oligonucleotide (ASO) Treatment in Epilepsy"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents